RIFAMPICIN (R), 600mg, powder, vial + solvent
STD
DINJRIFA6VS
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
22/10/2024, 12:20:19
Former
Code(s):
DINJRIFA6V-
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AB02
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
RIFAMPICIN
- Not in the WHO list of Essential Medicines 2023
Therapeutic Action
Rifamycin bactericidal
Indications
Drug-Sensitive Tuberculosis (DS-TB) in patients who are unable to tolerate oral therapy.
Instructions for use
Reconstitute the powder vial with the diluent supplied.
Must be given as slow IV infusion in 5% dextrose.
- Adult: single daily dose of 600 mg (over 2 to 3 hours)
- Children (< 12 years): single daily dose up to 20 mg/kg (do not exceed 600 mg daily)
Precautions for Use
Do not administer by direct IV route.
Storage
- Below 25°C
- After opening, use the product immediately.